Rejected
at 10:10 p.m. Feb, 18, 2024 ]
by
herstein.jacob
Author:
ansleyha
Type of change:
Updated content
Rationale for change
CDC Yellow Book says Nitazoxanide is FDA approved for use in immunocompetent only and has not been proven to help in immunosuppressed. It is a typo in First Aid 2023.
Rejection reason
Not an accepted source
Current
Suggested
Extra
Extra
Extra
Extra
Text
{{c2::Nitazoxanide}} is an antiprotozoal used exclusively* in {{c1::immunocompetent}} hosts to treat {{c3::Cryptosporidium}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
OME
Additional Resources
Empty field
One by one
Empty field